Abivax Announces Webcast and Teleconference Following Recent Oversubscribed Capital Increase of EUR 28m at Market Price
PARIS, FRANCE / ACCESSWIRE / November 2, 2020 / Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing...